TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/25 12:09 | 5/6/25 | OGN | Organon & Co. | Health | Drug | Pharmaceutical Preparations | Karp Daniel | NJ | O | EVP,Corp | P | 29 | 8.24 | 0 | 4 | 8 | 47 | D | |||||||||||||||
4/2/25 17:44 | 3/31/25 | OGN | Organon & Co. | Health | Drug | Pharmaceutical Preparations | Karp Daniel | NJ | O | EVP,Corp | M.d | 0 | 0.00 | 0 | 35 | 408 | 43 | D | |||||||||||||||
2/14/20 18:36 | 2/12/20 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Karp Daniel | MA | O | EVP,Corp | M.d | 0 | 0.00 | 0 | 1 | 1 | D | |||||||||||||||
7/5/19 16:51 | 7/2/19 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Karp Daniel | MA | O | EVP,Corp | M.d | 0 | 0.00 | 0 | 0 | 287 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |